Related Experiment Video
Updated: Aug 9, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Rapid-acting treatment for a common sleep problem
1Department of Child and Adolescent Psychiatry, Queen's Medical Centre, Nottingham, UK.
Insights
A behavioral intervention package significantly improved sleep patterns in children with severe learning disabilities and chronic sleep disorders. These positive sleep outcomes were sustained long-term, with additional benefits observed in daytime behavior.
Area of Science:
- Pediatrics
- Developmental Psychology
- Sleep Medicine
Background:
- Chronic sleep disorders are common in children with severe learning disabilities.
- These sleep issues can be handicapping and impact overall well-being.
- Existing interventions may have limited effectiveness or long-term data.
Purpose of the Study:
- To evaluate the effectiveness of a behavioral modification package for chronic sleep disorders in children with severe learning disabilities.
- To assess the short-term and long-term sustainability of the intervention's effects.
- To explore potential secondary benefits of the intervention.
Main Methods:
- A behavioral modification package including stimulus control, cueing, and rapid-extinction techniques was implemented.
- The intervention was applied to a group of 15 children with severe learning disabilities and chronic sleep disorders.
- Outcomes were assessed through night-settling and night-waking patterns, with follow-up at 18 months.
Main Results:
- Rapid improvements in night-settling and night-waking patterns were observed within days for most children.
- Positive sleep outcomes were sustained in 12 out of 15 children at 18-month follow-up.
- Secondary benefits, including improved daytime behavior and reduced maternal stress, were noted.
Conclusions:
- Behavioral interventions are effective for treating chronic sleep disorders in children with severe learning disabilities.
- The applied package demonstrates sustained efficacy and potential for wider application.
- Addressing sleep disorders in this population can lead to significant improvements in quality of life.
Abstract:
A behavioural modification package incorporating stimulus control, cueing, and rapid-extinction techniques was applied to a group of 15 children with severe learning disability who had chronic sleep disorders. Improvements in their night-settling and night-waking patterns occurred quickly (within a few days) and, in 12 of them, were sustained at medium- and long-term (18 months) follow-up. Additional improvements in the children's daytime behaviour and their mothers' subjective stress indices were observed, though not explicitly addressed. These results compare favourably with those of other studies which have tested behavioural interventions in other cohorts of children with sleep disorders. Wider application of behavioural interventions with these extremely common and potentially handicapping sleep disorders is recommended.
More Related Videos
05:59High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
04:53Acupoint Application Combined with Ear Plaster Therapy for Treating Sleep Disorders with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Published on: October 18, 2024
Related Concept Videos
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Management of Insomnia
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia
Multiple factors contribute...
Narcolepsy